Sign in
4

Changes in Ownership

Aurinia Pharmaceuticals Inc. Filed Acc 0001600620-26-000002

Chief Executive Officer gave up 113,169 shares (to pay taxes)

  • Chief Executive Officer acquired 165,384 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Greenleaf Peter Chief Executive Officer 2026-01-02 Grant or award +165,384 1,954,329 D: show line 1 in the form
Greenleaf Peter Chief Executive Officer 2026-01-02 Shares withheld for taxes −113,169 $15.95 $1,805,046 1,845,037 D: show line 2 in the form
Loading xslF345X05/wk-form4_1767647395.xml…